|
Synonyms: BMS-986460 | BMS986460 | Example 5 [US20250188056]
Compound class:
Synthetic organic
Comment: Orevandrodeg (BMS-986460) is an orally bioavailable androgen receptor targeting PROTAC [1]. It engages the cereblon (CRBN) E3 ubiquitin ligase.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Ligand families/groups | PROTACs, molecular glues and other degraders |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13808 | orevandrodeg |
Synonyms ![]() |
| BMS-986460 | BMS986460 | Example 5 [US20250188056] |
Database Links ![]() |
|
| CAS Registry No. | 2756845-16-4 (source: WHO INN record) |
| GtoPdb PubChem SID | 530846880 |
| PubChem CID | 166909510 |
| Search Google for chemical match using the InChIKey | SNTVVSHWBYMLQL-MQFDZLHLSA-N |
| Search Google for chemicals with the same backbone | SNTVVSHWBYMLQL |
| Search PubMed clinical trials | orevandrodeg |
| Search PubMed titles | orevandrodeg |
| Search PubMed titles/abstracts | orevandrodeg |
| UniChem Compound Search for chemical match using the InChIKey | SNTVVSHWBYMLQL-MQFDZLHLSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | SNTVVSHWBYMLQL-MQFDZLHLSA-N |